Mycophenolate mofetil
Jump to navigation
Jump to search
| Mycophenolate mofetil | |
|---|---|
| Term | Mycophenolate mofetil |
| Short definition | MYCN amplification study - A laboratory test that examines cells in a sample of tumor tissue or bone marrow to determine how many copies of the MYCN gene are present in the tumor DNA. MYCN is important for cell growth. |
| Type | Cancer terms |
| Specialty | Oncology |
| Language | English |
| Source | NCI |
| Comments | |
Mycophenolate mofetil - (pronounced) (my-koh-FEH-noh-layt MOH-feh-til) A drug used to prevent graft-versus-host disease (GVHD) after organ transplantation. It is also being studied for the prevention of GVHD after stem cell transplants for cancer and for the treatment of some autoimmune diseases. Mycophenolate mofetil is a type of immunosuppressive drug. Also called CellCept
External links
- Medical encyclopedia article on Mycophenolate mofetil
- Wikipedia's article - Mycophenolate mofetil
This MedicineGPT article is a stub. You can help make it a full article.
Languages: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski